MCQs on "Study of ER, PR, HER2/neu, p53, and Ki67 expression in primary breast carcinomas and synchronous metastatic axillary lymph nodes" Answers with Explanations and References

被引：0
|
作者：
不详
机构：
来源：
INDIAN JOURNAL OF CANCER | 2020年 / 57卷 / 02期
关键词：
ESTROGEN-RECEPTOR; CANCER;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：198 / 200
页数：3
相关论文
共 50 条
  • [31] Mitochondrial DNA alterations correlate with the pathological status and the immunological ER, PR, HER-2/neu, p53 and Ki-67 expression in breast invasive ductal carcinoma
    Lin, Chen-Sung
    Chang, Shi-Chuan
    Ou, Liang-Hung
    Chen, Chien-Ming
    Hsieh, Sophie Swen-Wan
    Chung, Yu-Ping
    King, Kuang-Liang
    Lin, Shoei-Loong
    Wei, Yau-Huei
    ONCOLOGY REPORTS, 2015, 33 (06) : 2924 - 2934
  • [32] Correlations between Expression of Ki67 with Her-2 and P53 Tumour Markers in Breast Cancer Patients
    Sheikhpour, R.
    Poorhosseini, F.
    WEST INDIAN MEDICAL JOURNAL, 2017, 66 (01): : 78 - 82
  • [33] Discordance and clinical significance of ER, PR, and HER2 status between primary breast cancer and synchronous axillary lymph node metastasis
    Zi-xiang Yao
    Lin-jie Lu
    Rui-jue Wang
    Liang-bin Jin
    Sheng-chun Liu
    Hong-yuan Li
    Guo-sheng Ren
    Kai-nan Wu
    De-lin Wang
    Ling-quan Kong
    Medical Oncology, 2014, 31
  • [34] Discordance and clinical significance of ER, PR, and HER2 status between primary breast cancer and synchronous axillary lymph node metastasis
    Yao, Zi-xiang
    Lu, Lin-jie
    Wang, Rui-jue
    Jin, Liang-bin
    Liu, Sheng-chun
    Li, Hong-yuan
    Ren, Guo-sheng
    Wu, Kai-nan
    Wang, De-lin
    Kong, Ling-quan
    MEDICAL ONCOLOGY, 2014, 31 (01)
  • [35] Biomarker (ER, PR, Her2 and Ki67) Testing On Core Needle Biopsy Specimens From Primary Breast Cancer - Their Usefulness and Limitations
    Nagaoka, H.
    Takahashi, T.
    Endo, K.
    Sugitani, K.
    Nakagami, K.
    Kim, Y.
    Yoshida, Y.
    Ooki, U.
    Horiguchi, J.
    Takeyoshi, I.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S92 - S92
  • [36] Topoisomerase II-alpha (Topo II-a) and HER2/neu expression in primary breast cancer and metastatic axillary nodes
    Anestakis, D.
    Nikolaidou, A.
    Dimitriadis, I
    Moysidis, I
    Baliaka, A.
    Patakiouta, F.
    VIRCHOWS ARCHIV, 2009, 455 : 185 - 185
  • [37] Expression of Biomarkers Estrogen Receptor, Progesterone Receptor, HER2 in Primary Breast Tumour and Synchronous Metastatic Axillary Lymph Node
    Mondal, Priyanka
    Rana, Satyadev
    Saha, Mautoshi
    Kundu, Sayan
    Chakraborty, Jayati
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (07)
  • [38] A Prospective Multi-Institutional Observational Study on ER, PR, HER2/NEU, and Ki-67 Expression and Discordance Pattern in Primary and Metastatic and Recurrent Carcinoma Breast and Its Therapeutic Implications and Prognostic Outcome
    Satishkumar, Maheswaran
    Ramesh, Muthuvel
    Sanjive, Jeevan G.
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2023, 14 (01) : 72 - 80
  • [39] A Prospective Multi-Institutional Observational Study on ER, PR, HER2/NEU, and Ki-67 Expression and Discordance Pattern in Primary and Metastatic and Recurrent Carcinoma Breast and Its Therapeutic Implications and Prognostic Outcome
    Maheswaran Satishkumar
    Muthuvel Ramesh
    Jeevan G. Sanjive
    Indian Journal of Surgical Oncology, 2023, 14 : 72 - 80
  • [40] Evaluation of HER2, p53, bcl-2, topoisomerase II-α, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodes
    Cardoso, F
    Di Leo, A
    Larsimont, D
    Gancberg, D
    Rouas, G
    Dolci, S
    Ferreira, F
    Paesmans, M
    Piccart, M
    ANNALS OF ONCOLOGY, 2001, 12 (05) : 615 - 620
12345